Abbott becomes the first company to officially stop imports of the drug-eluting cardiac stents on account of the price curbs.

The authority had asked the companies to consider options for price revision before deciding to withdraw their products from the market.

Coronary stents are wire mesh tubes inserted into coronary arteries to clear blockages and prevent heart attacks.

The maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...

Drug-eluting stents (DES) have a polymer coating over mesh that emits a drug over time that prevent blockage of arteries from recurring.

Abbott is selling its drug eluting stents, including the Xience Alpine, for the equivalent of Rs 29,000 to Rs 33,000 in many European count...

The prices of bare metal stents have gone up to Rs 7,400 from the earlier announced prices of Rs 7,260.

The instructions are being issued in public interest for compliance of ceiling prices by stent makers, distributors and hospitals, the NPPA...

Unlike drug-eluting stents that are made of metal and stay in the arteries forever, Meril’s 100 micron-thick BVS ‘MeRes100’ is made of mate...

The decision of the Department of Pharmaceuticals comes months after the Ministry of Health in July included stents in the National List of...

The observation comes at a time when India has decided to clamp price controls on stents and the govt is engaged with stakeholders in a rag...

In a letter to the secretary in the health ministry, the 4,500-member grouping has suggested that stents should be considered under differe...

As per the findings, the use of Everolimus eluting stents may be equally or more useful in treating coronary blockages in diabetic patients...

The final parameters to fix prices of stents will be based on the findings in the NHSRC report and the price lists submitted by manufacture...

Resolute Onyx DES which features the Core Wire Technology has thinner struts to help improve deliverability without compromising radial str...

Most patients are forced to pay anything between Rs 60,000 and Rs 1 lakh or more for cardiac drug eluting stents (DES).

The decision of Johnson&Johnson to stop making its popular drug eluting stent has opened up new opportunities for competitors Abbott & Bost...